| |
Home »
Shop » Drug
reviews
Drug Reviews
Drug
Reviews
For access to several hundred excellent drug reviews -
click
here
Allergic Rhinitis - Levocetirizine (in Primary Care)
Published by CSF Medical Communications
Our Price: £10.45 Special
offer!
Published within the Drugs in Context series. Editorial by Dr
Peter Howarth, Disease overview by Dr Richard Clark, Drug Review by Dr Richard
Clark and Improving Practice by Dr George Kassianos.
Angina -
Nicorandil (in Primary Care)
Published by CSF Medical Communications
Our Price: £10.45 Special offer!
Published within the Drugs in
Context series. Editorial by Professor Stewart Hillis, Disease overview by Dr
Richard Clark, Drug Review by Dr Richard Clark and Improving Practice by Dr
John Pittard.
Atorvastatin - Drug review
Published by CSF Medical
Communications
Our Price: £5.50
Published within the Drugs in
Context series, this thorough and independent expert review of the latest data
on Atorvastatin in lipid disorders was written by Dr Richard Clark and Dr
Eleanor Bull and peer-reviewed by specialists in the field.
Avaxim® - Drug review
Published by CSF Medical Communications
Our
Price: £5.50
Published within the Drugs in Context series, this
thorough and independent review of the latest data on avaxim in Hepatitis A was
written by Dr Eleanor Bull and peer-reviewed by specialists in the field.
Bisoprolol - Drug review
Published by CSF Medical Communications
Our Price: £5.50
Published within the Drugs in Context series, this
thorough and independent expert review of the latest data on Bisoprolol in
heart failure was written by Dr Duncan West and peer-reviewed by specialists in
the field.
BPH - Tamsulosin (in Primary Care)
Published by CSF
Medical Communications
Our Price: £10.45 Special offer!
Published within the Drugs in Context series. Editorial by Mr Christopher
Chapple, Disease overview by Dr Richard Clark, Drug Review by Dr Richard Clark
and Improving Practice by Dr Chris Barclay and Mr Christopher Chapple.
Calcipotriol - Drug review
Published by CSF Medical Communications
Our Price: £5.50
Published within the Drugs in Context series, this
thorough and independent review of the latest data on Calcipotriol in Psoriasis
was written by Dr Scott Chambers and Dr Richard Clark and peer-reviewed by
specialists in the field.
Candesartan - Drug review
Published by
CSF Medical Communications
Our Price: £5.50
Published within the
Drugs in Context series, this independent and thorough review of the latest
data on Candesartan in Hypertension and cardiovascular disease was written by
Dr Richard Clark and peer-reviewed by specialists in the field.
Cholera - DukoralTM (in Primary Care)
Published by CSF Medical
Communications
Published within the Drugs in Context series. Editorial
by Dr Jane Zuckerman, Disease overview by Dr Duncan West, Drug Review by Dr
Duncan West and Improving Practice by Dr George Kassionoss.
Clopidogrel - Drug review
Published by CSF Medical Communications
Our
Price: £5.50
Published within the Drugs in Context series, this
thorough and independent review of the latest data on Clopidogrel in
Atherothrombosis was written by Dr Scott Chambers and peer-reviewed by
specialists in the field.
Depression - Escitalopram (in Primary
Care)
Published by CSF Medical Communications
Our Price: £10.45
Special offer!
Published within the Drugs in Context series. Editorial by
Dr Graeme Whitfield and Dr Chris Williams, Disease overview by Dr Richard
Clark, Drug Review by Dr Richard Clark and Improving Practice by Dr George
Kassianos.
Depression - Venlafaxine (in Primary Care)
Published
by CSF Medical Communications
Our Price: £10.45 Special offer!
Published within the Drugs in Context series. Editorial by Professor Allan H
Young, Disease overview by Dr Richard Clark, Drug Review by Dr Richard Clark
and Improving Practice by Dr George Kassianos.
Desloratadine - Drug
review
Published by CSF Medical Communications
Our Price: £5.50
Published within the Drugs in Context series, this thorough and
independent review of the latest data on Desloratadine in Allergic rhinitis was
written by Dr Eleanor Bull and peer-reviewed by specialists in the field.
Donepezil - Drug review
Published by CSF Medical Communications
Our Price: £5.50
Published within the Drugs in Context series, this
thorough and independent review of the latest data on Donepezil in
Alzheimer’s dementia was written by Dr Eleanor Bull and peer-reviewed by
specialists in the field.
Dutasteride - Drug review
Published by
CSF Medical Communications
Our Price: £5.50
Published within the
Drugs in Context series, this thorough and independent review of the latest
data on Dutasteride in Benign prostatic hyperplasia was written by Dr Scott
Chambers and peer-reviewed by specialists in the field.
Eprosartan -
Drug review
Published by CSF Medical Communications
Our Price:
£5.50
Published within the Drugs in Context series, this thorough and
independent review of the latest data on Eprosartan in Hypertension and
cardiovascular disease was written by Dr Eleanor Bull and peer-reviewed by
specialists in the field.
Etoricoxib - Drug review
Published by
CSF Medical Communications
Our Price: £5.50
Published within the
Drugs in Context series, this thorough and independent review of the latest
data on Etoricoxib in Osteoarthritis was written by Dr Susan Chambers and Dr
Scott Chambers and peer-reviewed by specialists in the field.
Fentanyl - Drug review
Published by CSF Medical Communications
Our
Price: £5.50
Published within the Drugs in Context series, this
thorough and independent review of the latest data on Fentanyl in Chronic pain
was written by Dr Eleanor Bull and peer-reviewed by specialists in the field.
Fluvastatin - Drug review
Published by CSF Medical
Communications
Our Price: £5.50
Published within the Drugs in
Context series, this thorough and independent review of the latest data on
Fluvastatin in Lipid disorders as written by Dr Richard Clark and peer-reviewed
by specialists in the field.
GORD - Esomeprazole (in Primary
Care)
Published by CSF Medical Communications
Our Price: £10.45
Special offer!
Published within the Drugs in Context series. Editorial by
Dr Richard Stevens, Disease overview by Dr Richard Clark, Drug Review by Dr
Richard Clark and Improving Practice by Dr Chris Barclay and Mr Richard
Stevens.
Disclaimer
Net Media Marketing
excludes any warranty, express or implied, as to the quality, accuracy,
timeliness, completeness or fitness for a particular purpose of this briefing.
OnePharm Internet will not be liable for any claims, penalties, losses,
damages, costs, or expenses arising from the use of or inability to use this
briefing or from any unauthorised access to or alteration of the Briefing.
OnePharm Internet makes no warranty that the contents of this briefing are
compatible with all computer systems and browsers.
|
